Bifidobacterium longum APC1472
Bifidobacterium longum APC1472 has been studied in the context of obesity and metabolic health, with at least one published randomized controlled trial examining human participants alongside parallel rodent work. More recent animal research has examined feeding-behavior patterns following early-life dietary stress, and in vitro work has examined hypothalamic gene expression involved in appetite regulation. The available evidence is early-stage and does not establish efficacy for weight management in people; further human trials are needed. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 4 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
4 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41044088 →In vitro assessment of bacterial supernatants on hypothalamic gene expression: implications for appetite regulation· npj Biofilms and Microbiomes · 2025